EP1755677A4 - Sechage de substances bioactives par pulverisation a haute pression - Google Patents

Sechage de substances bioactives par pulverisation a haute pression

Info

Publication number
EP1755677A4
EP1755677A4 EP05770439A EP05770439A EP1755677A4 EP 1755677 A4 EP1755677 A4 EP 1755677A4 EP 05770439 A EP05770439 A EP 05770439A EP 05770439 A EP05770439 A EP 05770439A EP 1755677 A4 EP1755677 A4 EP 1755677A4
Authority
EP
European Patent Office
Prior art keywords
dry
high pressure
pressure spray
bioactive materials
bioactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05770439A
Other languages
German (de)
English (en)
Other versions
EP1755677A2 (fr
Inventor
Vu Truong-Le
Tom Scherer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune Vaccines Inc filed Critical MedImmune Vaccines Inc
Publication of EP1755677A2 publication Critical patent/EP1755677A2/fr
Publication of EP1755677A4 publication Critical patent/EP1755677A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP05770439A 2004-06-14 2005-06-13 Sechage de substances bioactives par pulverisation a haute pression Withdrawn EP1755677A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57985004P 2004-06-14 2004-06-14
PCT/US2005/020792 WO2005123131A2 (fr) 2004-06-14 2005-06-13 Sechage de substances bioactives par pulverisation a haute pression

Publications (2)

Publication Number Publication Date
EP1755677A2 EP1755677A2 (fr) 2007-02-28
EP1755677A4 true EP1755677A4 (fr) 2009-11-25

Family

ID=35510270

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05770439A Withdrawn EP1755677A4 (fr) 2004-06-14 2005-06-13 Sechage de substances bioactives par pulverisation a haute pression

Country Status (5)

Country Link
EP (1) EP1755677A4 (fr)
JP (1) JP2008505192A (fr)
AU (1) AU2005254062B2 (fr)
CA (1) CA2564791A1 (fr)
WO (1) WO2005123131A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2566079A1 (fr) 2004-05-12 2005-12-01 Terrence L. Scott Production et administration de microspheres d'acide nucleique
WO2005112885A2 (fr) 2004-05-12 2005-12-01 Baxter International Inc. Administration de microspheres d'oligonucleotides antisens pour induire une tolerance de cellules dendritiques pour le traitement du diabete de type 1 insulino-dependant
EP1834651A1 (fr) * 2006-03-15 2007-09-19 Universiteit Gent Nouvelles compositions de vaccins et procédés de préparation de vaccins pour des maladies vétérinaires
US8268354B2 (en) * 2007-11-07 2012-09-18 Aridis Pharmaceuticals Sonic low pressure spray drying
AU2009299615B2 (en) 2008-10-02 2015-07-16 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
DK2432502T3 (en) 2009-05-20 2018-03-12 Aeras STABLE, SPRAY DRIED, IMMUNOGENE, VIRUS COMPOSITIONS
EP3409289B1 (fr) 2010-02-26 2020-09-30 Novo Nordisk A/S Compositions contenant un anticorps stable
RS59830B1 (sr) 2010-03-01 2020-02-28 Bayer Healthcare Llc Optimizovana monoklonska antitela protiv inhibitora puta faktora tkiva (tfpi)
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
US9468679B2 (en) 2011-03-28 2016-10-18 Ablynx N.V. Method for producing solid formulations comprising immunoglobulin single variable domains
ITMI20112042A1 (it) * 2011-11-10 2013-05-11 Eratech S R L Polvere da ricostituire prima dell'uso comprendente melatonina e preparazione iniettabile ottenibile da tale polvere.
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations
JP2016515934A (ja) * 2013-03-28 2016-06-02 インスティロ ゲーエムベーハー 分散物および固体の生産のための装置および方法
EP3532500A1 (fr) * 2016-10-31 2019-09-04 Vectura Limited Composition de poudre inhalable comprenant un anticorps il -13
EP3459529A1 (fr) * 2017-09-20 2019-03-27 Tillotts Pharma Ag Préparation de formes posologiques solides à libération prolongée comprenant des anticorps par séchage par pulvérisation
GB201718888D0 (en) * 2017-11-15 2017-12-27 Ucb Biopharma Sprl Method
RS66646B1 (sr) * 2019-10-28 2025-04-30 Medimmune Ltd Formulacije suvog praška vezujućih antitela za timusni stromalni limfopoetin (tslp) i postupci njihove upotrebe

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531580B1 (en) * 1999-06-24 2003-03-11 Ixsys, Inc. Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
US20030091584A1 (en) * 2000-11-28 2003-05-15 Young James F. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
WO2003087335A2 (fr) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Conservation de matieres bioactives par sechage par pulverisation
WO2004058156A2 (fr) * 2002-12-17 2004-07-15 Medimmune Vaccines, Inc. Pulvérisation haute pression de matériaux bioactifs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0913177A1 (fr) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Procédé pour produire des produits amorphe, sec comprenant de la matière biologique active par séchage convectif, spécialement söchage par pulvérisation
AU2003230908A1 (en) * 2002-04-11 2003-10-27 Medimmune Vaccines, Inc. Spray freeze dry of compositions for intranasal administration
AU2003234090A1 (en) * 2002-04-11 2003-10-27 Medimmune Vaccines, Inc. Spray freeze dry of compositions for pulmonary administration

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531580B1 (en) * 1999-06-24 2003-03-11 Ixsys, Inc. Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
US20030091584A1 (en) * 2000-11-28 2003-05-15 Young James F. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
WO2003087335A2 (fr) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Conservation de matieres bioactives par sechage par pulverisation
WO2004058156A2 (fr) * 2002-12-17 2004-07-15 Medimmune Vaccines, Inc. Pulvérisation haute pression de matériaux bioactifs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BREEN E D ET AL: "Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation", PHARMACEUTICAL RESEARCH 2001 US, vol. 18, no. 9, 2001, pages 1345 - 1353, XP002550626, ISSN: 0724-8741 *

Also Published As

Publication number Publication date
JP2008505192A (ja) 2008-02-21
WO2005123131A2 (fr) 2005-12-29
CA2564791A1 (fr) 2005-12-29
EP1755677A2 (fr) 2007-02-28
AU2005254062B2 (en) 2011-02-17
AU2005254062A1 (en) 2005-12-29
WO2005123131A3 (fr) 2008-01-03

Similar Documents

Publication Publication Date Title
EP1581639A4 (fr) Pulv risation haute pression de mat riaux bioactifs
IL191356A0 (en) Therapeutic materials
IL216401A0 (en) Sustained release of antinfectives
IL184036A0 (en) Preparation of rosuvastatin
IL187949A0 (en) Diastereomeric purification of rosuvastatin
IL192425A0 (en) Carbonates of fenicol antibiotics
IL185939A0 (en) Preparation of paricalcitol
EP1973525A4 (fr) Articles médicaux contenant une émulsion
GB0505975D0 (en) Novel use of peptide
DK2392335T3 (en) Use of 24-norUDCA
GB0521261D0 (en) Prepartaion of bone material
GB2423583B (en) Manufacture of interactive surface
IL187948A0 (en) Preparation of rosuvastatin
EP1721158A4 (fr) Modulateurs d'angiogenese
EP1740198A4 (fr) Effets anti-age de la substance p
GB0526120D0 (en) Therapeutic peptides
ZA200805673B (en) Carbonates of fenicol antibiotics
EP1858509A4 (fr) Nouveaux inhibiteurs de cathepsine c et leur utilisation
HK1082186A (en) High pressure spray-dry of bioactive materials
ZA200708109B (en) Method of peptide synthesis
GB0623352D0 (en) Foot massager
GB2426775B (en) Chamber riser
GB0405190D0 (en) Purification of peptides
GB0512574D0 (en) Uses of (s)-clenbuterol
GB0412138D0 (en) Definition of zeroclick

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061204

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

DAX Request for extension of the european patent (deleted)
PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/715 20060101ALI20080122BHEP

Ipc: A61K 9/14 20060101ALI20080122BHEP

Ipc: A61K 39/215 20060101ALI20080122BHEP

Ipc: A61K 39/155 20060101ALI20080122BHEP

Ipc: A61K 39/12 20060101AFI20080122BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20091028

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MEDIMMUNE, LLC

17Q First examination report despatched

Effective date: 20100421

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120417